Cervical cancer, papillomavirus, and miRNA dysfunction

EG Bañuelos-Villegas, MF Pérez-yPérez… - Frontiers in Molecular …, 2021 - frontiersin.org
Cervical cancer is the leading cause of death by cancer in women from developing
countries. Persistent infection with high-risk human papillomavirus (HPV) types 16 and 18 is …

Human papillomavirus and cervical cancer: An insight highlighting pathogenesis and targeting strategies

PS Ojha, MM Maste, S Tubachi, VS Patil - Virusdisease, 2022 - Springer
Background Cervical cancer is marked by the uncontrolled proliferation and division of cells
making up the cervix. Because of its enormous population, Asia accounts for more than half …

A systematic review and meta-analysis of miRNAs for the detection of cervical cancer

CRT Hillyar, SS Kanabar, KR Pufal, JL Saw Hee… - …, 2023 - Taylor & Francis
Aim: This study aimed to critically appraise the evidence of the diagnostic effectiveness of
miRNAs for the detection of cervical cancer. Methods & materials: A systematic review and …

[PDF][PDF] 表皮生长因子受体靶向治疗宫颈癌的研究进展

韩布威, 刘洋, 刘宁, 郝新颖, 周丽娜, 亓丁… - 中国医药 …, 2023 - yiyaodaobao.com.cn
宫颈癌的发生普遍与人乳头瘤病毒(HPV) 感染有关, 而HPV 感染与表皮生长因子受体(EGFR)
信号级联上调之间存在较大的相关性, 因此, EGFR 通常被作为靶点并使用酪氨酸激酶抑制剂和 …

Analysis of Human Papillomavirus-Associated Cervical Cancer Differentially Expressed Genes and Identification of Prognostic Factors using Integrated Bioinformatics …

S Hatefi-Shogae, M Emadi-Baygi… - Advanced Biomedical …, 2024 - journals.lww.com
Background: Human papillomavirus (HPV)-induced cervical cancer progresses through a
series of steps. Despite our limited understanding of the mechanisms driving this …

Progression Pathways of Human Papillomavirus-Associated Cancer

N Velázquez-Márquez, S Velázquez-Márquez… - … Associated with the …, 2024 - Springer
Human Papillomavirus (HPV) accounts for approximately 30% of all cancers caused by
infectious agents. HPV consists of small, non-enveloped DNA viruses belonging to the …

Servikal intraepitelyal neoplazi (CIN) tanılı hastalarda yüksek riskli HPV persistansı olan ve olmayan gruplarda farklı mikrorna değerlerinin karşılaştırılması

A Akkoç - 2024 - gcris.pau.edu.tr
Serviks kanseri kadınlarda dördüncü en sık görülen jinekolojik kanserdir. Son yıllarda aşı
uygulamaları ve tarama programları ile erken teşhis ve önlemede ilerleme kaydedilmiş olsa …